Cover Image

Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src Inhibitor

Src is a non-receptor tyrosine kinase (TK) whose involvement in cancer, including glioblastoma (GBM), has been extensively demonstrated. In this context, we started from our <i>in-house</i> library of pyrazolo[3,4-<i>d</i>]pyrimidines that are active as Src and/or Bcr-Abl TK...

Full description

Saved in:

Bibliographic Details
Main Authors:	Claudia Contadini (Author), Claudia Cirotti (Author), Anna Carbone (Author), Mehrdad Norouzi (Author), Annarita Cianciusi (Author), Emmanuele Crespan (Author), Cecilia Perini (Author), Giovanni Maga (Author), Daniela Barilà (Author), Francesca Musumeci (Author), Silvia Schenone (Author)
Format:	Book
Published:	MDPI AG, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme
by: Federica Poggialini, et al.
Published: (2023)

Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment
by: Marina Massaro, et al.
Published: (2024)

Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits Interaction
by: Ilaria Giacchello, et al.
Published: (2024)

Synthesis and biological activity evaluation of 3-(hetero) arylideneindolin-2-ones as potential c-Src inhibitors
by: Salvatore Princiotto, et al.
Published: (2022)

A PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND REDUCES CELL VIABILITY AND INDUCES APOPTOSIS IN DIFFERENT HEMATOLOGICAL MALIGNANCIES
by: Ilaria Laurenzana, et al.
Published: (2016)

Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016)

Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
by: Asmaa A. Mandour, et al.
Published: (2022)

Synthesis of some novel pyrazolo[3,4-d] pyrimidin-4(5H)-one derivatives as potential antimicrobial agent
by: Dipen K Sureja, et al.
Published: (2016)

Design, ADMET, PASS Prediction and Molecular Docking Studies of Novel pyrazolo[3,4-d]pyrimidines for Prospective of Anti-Cancer Agents
by: Sathish Mittapalli, et al.
Published: (2023)

Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors
by: Mater Mahnashi, et al.
Published: (2023)

Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M
by: Ahmed A. Gaber, et al.
Published: (2022)

Synthesis and Structure-Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl-<i>N</i>-(Pyridin-2-ylmethyl)Pyrazolo[1,5-<i>a</i>]Pyrimidin-7-Amines
by: Hamish S. Sutherland, et al.
Published: (2022)

Design, Synthesis, and Development of pyrazolo[1,5-<i>a</i>]pyrimidine Derivatives as a Novel Series of Selective PI3K<i>δ</i> Inhibitors: Part I-Indole Derivatives
by: Mariola Stypik, et al.
Published: (2022)

Design, synthesis and antitumor evaluation of novel pyrazolo[3,4-d]pyrimidines incorporating different amino acid conjugates as potential DHFR inhibitors
by: Ibrahim M. Salem, et al.
Published: (2023)

The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl<sub>4</sub>-Induced Liver Fibrosis in Rats
by: Diana K. Ghobrial, et al.
Published: (2023)

Design, Synthesis, and Development of Pyrazolo[1,5-<i>a</i>]pyrimidine Derivatives as a Novel Series of Selective PI3K<i>δ</i> Inhibitors: Part II-Benzimidazole Derivatives
by: Mariola Stypik, et al.
Published: (2022)

Discovery of Novel Dual Adenosine A<sub>2A</sub> and A<sub>1</sub> Receptor Antagonists with 1<i>H</i>-Pyrazolo[3,4<i>-d</i>]pyrimidin-6-amine Core Scaffold as Anti-Parkinson's Disease Agents
by: Juyoung Jung, et al.
Published: (2022)

Design and synthesis of novel pyrazolo[4,3-d]pyrimidines as potential therapeutic agents for acute lung injury
by: Bao Shi Wang, et al.
Published: (2019)

Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016)

Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5-<i>a</i>]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies
by: Ahmed Ragab, et al.
Published: (2023)

Targeting p21-activated kinase 4 (PAK4) with pyrazolo[3,4-d]pyrimidine derivative SPA7012 attenuates hepatic ischaemia-reperfusion injury in mice
by: Yuancheng Mao, et al.
Published: (2022)

Discovery of New 1,4,6-Trisubstituted-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer
by: Maria Georgiou, et al.
Published: (2023)

DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy
by: Yue Sheng, et al.
Published: (2015)

Design, synthesis, docking, and antimicrobial evaluation of some novel pyrazolo[1,5-a]pyrimidines and their corresponding cycloalkane ring-fused derivatives as purine analogs
by: Abdallah AEM, et al.
Published: (2018)

Design, Synthesis, In Vitro, and In Silico Studies of New <i>N</i><sup>5</sup>-Substituted-pyrazolo[3,4-<i>d</i>]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors
by: Waheed A. Zaki, et al.
Published: (2023)

Scientific American Supplement, No. 388, June 9, 1883
by: Various

Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-<i>f</i>]quinoline Derivatives
by: Chhabi Lal Chaudhary, et al.
Published: (2022)

Modular Synthesis and Antiproliferative Activity of New Dihydro-1<i>H</i>-pyrazolo[1,3-<i>b</i>]pyridine Embelin Derivatives
by: Pedro Martín-Acosta, et al.
Published: (2021)

Induction of Paraptotic Cell Death in Breast Cancer Cells by a Novel Pyrazolo[3,4-<i>h</i>]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress
by: Phuong Linh Nguyen, et al.
Published: (2022)

Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis
by: Mai Maher, et al.
Published: (2019)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-<i>d</i>], [3,2-<i>d</i>], [3,4-<i>d</i>] and [4,3-<i>d</i>]pyrimidine Derivatives
by: Joana F. Campos, et al.
Published: (2022)

Blackwood's Edinburgh Magazine, Vol. 63, No. 388, February 1848
by: Various

Effective Activation of BK<sub>Ca</sub> Channels by QO-40 (5-(Chloromethyl)-3-(Naphthalen-1-yl)-2-(Trifluoromethyl)Pyrazolo [1,5-a]pyrimidin-7(4<i>H</i>)-one), Known to Be an Opener of KCNQ2/Q3 Channels
by: Wei-Ting Chang, et al.
Published: (2021)

Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel <i>h</i>LDHA Inhibitors
by: Iván Díaz, et al.
Published: (2022)

Antiproliferative Activity of Triterpenoid and Steroid Compounds from Ethyl Acetate Extract of <i>Calotropis gigantea</i> Root Bark against P388 Murine Leukemia Cell Lines
by: Kartini Hasballah, et al.
Published: (2021)

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
by: Xiaowei Wu, et al.
Published: (2021)

The Mirror of Literature, Amusement, and Instruction. Volume 14, No. 388, September 5, 1829
by: Various

Effects of Naringin on Hydrogen Peroxide-Induced Cytotoxicity and Apoptosis in P388 Cells
by: Syu-ichi Kanno, et al.
Published: (2003)

4-Substituted Thieno[3,2-<i>d</i>]pyrimidines as Dual-Stage Antiplasmodial Derivatives
by: Prisca Lagardère, et al.
Published: (2022)

Ljudje odprtih src Slovenski misijonarji o sebi
by: Žigon, Zvone
Published: (2005)